HVRDe009-A-2

HUES9 CTNNB1 3X FLAG

General

Cell Line

hPSCreg Name
HVRDe009-A-2
Alternative name(s)
HUES9 CTNNB1 3X FLAG
Cell line type Human embryonic stem cell (hESC)
Last update 4th November 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Arizona State University (ASU)
Derivation country United States

External Databases

BioSamples SAMEA9005187
CLO CLO_0103343
Cellosaurus CVCL_A8QB
Wikidata Q108820516

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

External Databases (Donor)

BioSamples SAMEA8944198

Ethics

Also have a look at the ethics information for the parental line HVRDe009-A .

hESC Derivation

The source cell information can be found in the parental cell line HVRDe009-A.

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
Accutase
CO2 Concentration 5 %
Medium Essential 8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line HVRDe009-A .

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX, inv(9)
Passage number: 65
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
CTNNB1 (target)
Transgene expression
3p22.1
HUES9 line with 3X FLAG at C-terminal CTNNB1 gene. 3X FLAG sequence inserted using CRISPR/Cas9. Plasmids introduced using electroporation.
CRISPR-associated (CRISPR/Cas) System